Bowen Acquisition Corp (BOWNU) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
420 LEXINGTON AVE, SUITE 2446 NEW YORK, NY 10170 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 284 - Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 103,774 | 426,913 | |||
| Cash and cash equivalent | 103,774 | 426,913 | |||
| Receivables | 138,046 | ||||
| Prepaid expense | 12,239 | 79,481 | |||
| Total current assets: | 254,059 | 506,394 | |||
| Noncurrent Assets | |||||
| Asset, held-in-trust | 75,794,241 | 71,419,358 | |||
| Total noncurrent assets: | 75,794,241 | 71,419,358 | |||
| TOTAL ASSETS: | 76,048,300 | 71,925,752 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 200,000 | ||||
| Accounts payable | 200,000 | ||||
| Derivative instruments and hedges, liabilities | |||||
| Other undisclosed current liabilities | 1,053,115 | (96,140) | |||
| Total current liabilities: | 1,053,115 | 103,860 | |||
| Noncurrent Liabilities | |||||
| Total liabilities: | 1,053,115 | 103,860 | |||
| Temporary equity, including noncontrolling interest | 75,794,241 | 71,419,358 | |||
| Equity | |||||
| Equity, attributable to parent | (799,056) | 402,534 | |||
| Common stock | 227 | 227 | |||
| Additional paid in capital | |||||
| Retained earnings (accumulated deficit) | (799,283) | 402,307 | |||
| Total equity: | (799,056) | 402,534 | |||
| TOTAL LIABILITIES AND EQUITY: | 76,048,300 | 71,925,752 | |||
Income Statement (P&L) (USD)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|
| Gross profit: | ||||
| Operating expenses | (633,764) | |||
| Other undisclosed operating income | ||||
| Operating loss: | (633,764) | |||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 3,597,616 | |||
| Interest and debt expense | (87,267) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||
| Net income (loss): | 2,876,585 | |||
| Other undisclosed net income attributable to parent | 87,267 | |||
| Net income (loss) available to common stockholders, diluted: | 2,963,852 | |||
Comprehensive Income (USD)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|
| Net income (loss): | 2,876,585 | |||
| Comprehensive income (loss), net of tax, attributable to parent: | 2,876,585 | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.